| Literature DB >> 24210793 |
Lisa M Kosloski1, Elizabeth A Kosmacek, Katherine E Olson, R Lee Mosley, Howard E Gendelman.
Abstract
Innate and adaptive immune responses can speed nigrostriatal neurodegeneration in Parkinson's disease (PD). We posit that GM-CSF can attenuate such responses. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxicated mice, GM-CSF given prior to MPTP protected nigral dopaminergic neurons coincident with altered microglial morphologies and regulatory T cell (Treg) induction. Adoptive transfer of GM-CSF-induced Treg to MPTP mice protected nigral neurons. Gene expression analyses revealed novel immune-based neuronal protection pathways linked to the upregulation of IL-27. The results provide evidence that GM-CSF modulation of immunity could be of clinical benefit for PD.Entities:
Keywords: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Innate immunity; Neuroinflammation; Neuroprotection; Parkinson's disease; Regulatory T cells
Mesh:
Substances:
Year: 2013 PMID: 24210793 PMCID: PMC3872482 DOI: 10.1016/j.jneuroim.2013.10.009
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478